Roche licenses Rona Therapeutics’ ALK7-targeting RNAi candidate for obesity, while Pfizer partners with Enodia Therapeutics ...

Fox Rothschild's Mark Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and ...

Since prediction market platforms such as Kalshi began offering trade markets on regulatory reviews and clinical trial ...

PaxSafe's Mark Talens on why pharma supply chain AI fails before it starts — and the data foundry framework that changes that. Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at ...

If AI is taking over the routine assignments that have traditionally supported an apprenticeship model, through which new ...

Thomas Appio has been named interim CEO of Bausch + Lomb, a move coinciding with an expected upward revision to the company’s ...

Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at LogiPharma 2026 in Boston. During the conversation., the ...

Drug shortages remain a difficult to fix issue for the pharma industry and are an issue that can have devastating results.

Biotech startups face high failure rates, with nearly 90% failing and only 28% of first-time product launches exceeding forecasts. Early integration of commercialization strategies is crucial for ...

A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability ...

Tukysa adds a chemotherapy-free maintenance option for HER2-positive metastatic breast cancer; liver toxicity monitoring ...

Caribou Biosciences discontinues its two allogeneic CAR-T programs, Kamal Biswas makes the case for continuous quality ...